Status:
COMPLETED
Diaphragm Thickness by Ultrasonography in Neurological Disorders
Lead Sponsor:
Mansoura University
Conditions:
Guillain-Barre Syndrome
Myasthenia Gravis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
participants will be allocated into three groups, acute neuropathy (Guillain Barre Syndrome) group, neuromuscular junction disorder(myasthenia gravis ) group, and control group(people with neurologica...
Detailed Description
after IRB (institutional research board ) approval, of the faculty of medicine, Mansoura University, Egypt, written informed consent from all participants will be taken. participants will be allocated...
Eligibility Criteria
Inclusion
- all adult patients admitted to the neurology department
Exclusion
- cardiopulmonary diseases
- chest trauma
- diaphragmatic diseases
- Body Mass Index (BMI) \> 30
Key Trial Info
Start Date :
April 13 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 13 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05324176
Start Date
April 13 2022
End Date
May 13 2022
Last Update
May 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura University Hospitals
Al Mansurah, Not in US Or Canada, Egypt, 35516